标题 |
专利、报告等 Cadonilimab plus chemotherapy versus chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (COMPASSION-15): A randomized, double-blind, phase 3 trial
卡多尼单抗联合化疗与化疗一线治疗不可切除的局部晚期或转移性胃或胃食管结合部(G/GEJ)腺癌(COMPASSION-15):一项随机、双盲、3期试验
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | 2024AACR年会 摘要号:CT006 |
求助人 | |
下载 |